Qiming Venture Partners USA
Venture Capital
Active
Seattle, United States
31
64M
20
1.72
4
0.35
3
- Stages of investment
- Areas of investment
Summary
Qiming Venture Partners USA is the famous VC, which was founded in 2006.
The overall number of key employees were 12.
The usual cause for the fund is to invest in rounds with 4 partakers. The meaningful sponsors for the fund in investment in the same round are Surveyor Capital, Sanofi, NanoDimension. In the next rounds fund is usually obtained by Roche Venture Fund.
Among the various public portfolio startups of the fund, we may underline Icosavax Among the most popular fund investment industries, there are Health Care, Biotechnology. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund.
The fund is generally included in 2-6 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2019.
Investor highlights
- Industry focus
- Stage focus
- Geo focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Last fund
- Fund size
- RMB 6500000000
- Fund raised date
- 2023-05-18
Analytics
- Total investments
- 31
- Lead investments
- 4
- Exits
- 3
- Rounds per year
- 1.72
- Follow on index
- 0.35
- Investments by industry
- Biotechnology (22)
- Health Care (19)
- Pharmaceutical (13)
- Biopharma (6)
- Medical (6) Show 15 more
- Investments by region
-
- United States (18)
- Latvia (5)
- Canada (2)
- China (3)
- United Kingdom (1)
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 81M
- Group Appearance index
- 1.00
- Avg. company exit year
- 3
- Avg. multiplicator
- 1.56
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Ventyx Biosciences | 20 Sep 2021 | Biotechnology, Biopharma | Early Stage Venture | 51M | United States, California, Encinitas |
| Viewtrix Technology | 01 Sep 2019 | Late Stage Venture | Shenzhen, Guangdong, China |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.